74713-58-9 SF3LP91341 Ceramide 4 UNII-SF3LP91341 Butanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)- Butanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))- Ceramide 4 (retired) [INCI] Ceramide as (ceramide 4) Ceramide as (ceramide 4) [INCI] N-Butyryl-D-erythro-sphingosine
| CAS 号 | 74713-58-9 |
| 分子式 | C22H43NO3 |
| 分子量 | 369.58 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
本产品为药物标准品C4 Ceramide (d18:1/4:0)(74713-58-9 SF3LP91341 Ceramide 4 UNII-SF3LP91341 Butanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)- Butanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))- Ceramide 4 (retired) [INCI] Ceramide as (ceramide 4) Ceramide as (ceramide 4) [INCI] N-Butyryl-D-erythro-sphingosine,CAS 74713-58-9),分子式 C22H43NO3,分子量 369.58。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
本品定值报告包含以下质量控制信息: - 主成分含量:97%+; - 水分/残留溶剂:通过卡尔费休(KF)和热重分析(TGA)测定并校正; - 定值方法:HPLC-DAD面积归一化法、qNMR法、DSC法等正交验证; - 不确定度:扩展不确定度(k=2)包含测量重复性、均匀性和稳定性分量。 化学式为 C22H43NO3 的C4 Ceramide (d18:1/4:0)(74713-58-9 SF3LP91341 Ceramide 4 UNII-SF3LP91341 Butanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)- Butanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R,S-(E)))- Ceramide 4 (retired) INCI Ceramide as (ceramide 4) Ceramide as (ceramide 4) INCI N-Butyryl-D-
应用场景:C4 Ceramide (d18:1/4:0)(74713-58-9 SF3LP91341 Ceramide 4 UNII-SF3LP91341 Butanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)- Butanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R ,S -(E)))- Ceramide 4 (retired) INCI Ceramide as (ceramide 4) Ceramide as (ceramide
| 中文名称 | C4 Ceramide (d18:1/4:0) |
| 分子式 | C22H43NO3 |
| 分子量 | 369.58 g/mol |
| 外观形态 | 白色至类白色结晶性粉末 |
| 纯度 | 97%+ |
| 储存条件 | 2-8°C冷藏保存,避光,密封防潮 |
| 溶解性参考 | 可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO |
| 稳定性 | 对光敏感,应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 2.0 |
| CAS登记年份(估) | 1978年 |
| 含氮原子数 | 1 |